|Written by Steve Hercenberg, CFA|
|Tuesday, 21 October 2014 07:36|
Over the past month, stock markets worldwide have been in a tailspin. Meanwhile, the dollar continues to strengthen, which would have a dampening effect on the growth of exports by large cap US companies. Weakening economies in Europe and Asia are further exacerbating future demand for US products in general. Fortunately, the Fed's accommodative efforts to keep interest rates low, have continued to support our economy. The low interest rate environment has also enabled cash-rich large cap businesses to acquire/merge smaller ones that have minimum exposure to overseas markets. So, unfolding developments could strongly favor small cap stocks in the U.S. in the months ahead.
Small caps are especially attractive now because they have been out of favor. Over the long term, little companies beat big ones. Small-company stocks are having a lousy 2014. So far this year, the group, as measured by the Russell 2000 index (RUT), is roughly down 5%, and it trails Standard & Poor's 500-stock index (SPX), which measures large-cap stocks, by a whopping nine percentage points. One way to take advantage of this imbalance in values is to invest in a wide range of undervalued small cap stocks.
Over the last five trading days, we have already witnessed a turnaround in the Russell 2000. The Dow and S&P also appear to be approaching a turning point. While buying now could feel like catching a falling knife, as Warren Buffett has repeatedly advised: it's best to buy when everyone is fearful.
Guggenheim S&P SmallCap 600 Pure Value ETF (NYSE-RZV- $57.52) tracks a fundamentally weighted index of US listed small-cap value companies. Its proprietary weighting strategy and focus overweights the portfolio with microcaps. This microcap concentration greatly raises market risk (beta of 1.45) and squashes dividend yield of 0.73%. RZV's portfolio also has several sector bets. It overweights industrials, information technology, and consumer cyclicals while it underweights financials and real estate. So, the top three sectors collectively make up over 52% of total assets. RZV's portfolio is widely spread across 153 securities since each holding accounts for less than 2% of the fund. RZV's Total Assets exceed $156 million while average daily volume is low at nearly 25,000 shares.
Since the fund is non-diversified and not actively managed, the ETF charges 35 bps in annual fees.
Given its narrow segment focus, this ETF would work best as a satellite holding in a diversified portfolio. We recommend buying RZV with a target price ranging from $68 to $72 within the next 12 months.
Disclosure: Goldman Small Cap Research analysts are neither long nor short these shares but may elect to purchase the stock within the next 48 hours.
This Market Monitor blog was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces research via two formats: Goldman Select Research, which typically highlights small cap companies, and Goldman Opportunity Research, which features micro cap companies in a sponsored research format. Thus, the Select product reflects the Firm's internally generated stock ideas while the Opportunity product reflects sponsored research reports.
Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
It is important to note that while we may track performance separately, we utilize the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company's individual disclosures for each engagement, which can be found in each company-specific report. All information contained in this blog, newsletter and in our reports were provided by the Companies or generated from our own due diligence. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence. Analysts are compensated on a per report basis and not on the basis of his/her recommendations.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, or other firms. Goldman Small Cap Research relied solely upon information provided by the Company through its filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research blog, report, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed.
This blog does not take into account the investment objectives, financial situation, or particular needs of any particular person. This blog does not provide all information material to an investor's decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with FINRA or with any state securities regulatory authority.
ALL INFORMATION IN THIS BLOG, REPORT OR NEWSLETTER IS PROVIDED "AS IS" WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.